Supplerende behandling hos patienter, som er sygdomsfri efter operation, men har høj risiko for tilbagefald, for eksempel patienter med primær eller recidiverende (klinisk eller patologisk) lymfeknudepåvirkning.
As adjuvant therapy in patients who are free of disease after surgery but are at high risk of systemic recurrence, e.g., patients with primary or recurrent (clinical or pathological) lymph node involvement.